Mankind Pharma Limited (NSE: MANKIND), ISIN INE634S01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MANKIND last traded at ₹2585.80 (-0.26%), with a 52-week range of ₹1909.90 to ₹2670.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 72.63%, FIIs 9.45%, DIIs 15.39%, mutual funds 10.87%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.